Rifampicin 450 mg - search results

Philippines - English - FDA (Food And Drug Administration)

duasaph-450 450 mg/400 mg film-coated tablet

sapphire lifesciences pvt. ltd.; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - rifampicin , isoniazid - film-coated tablet - 450 mg/400 mg

Philippines - English - FDA (Food And Drug Administration)

duasaph-450 450 mg/400 mg film-coated tablet

aaron healthcare and export pvt. ltd.; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - rifampicin , isoniazid - film-coated tablet - 450 mg/400 mg

Uganda - English - National Drug Authority

rifampicin/isoniazid/ethambutol 150mg+75mg+275mg oral solid ordinary film-coated tablets

macleods pharmaceuticals ltd - rifampicin+isoniazid+ethambutol - oral solid ordinary film-coated tablets - 150mg+75mg+275mg

Australia - English - Department of Health (Therapeutic Goods Administration)

rifadin rifampicin 20mg/ml oral liquid bottle

sanofi-aventis australia pty ltd - rifampicin, quantity: 20 mg/ml - oral liquid - excipient ingredients: agar; sucrose; methyl hydroxybenzoate; propyl hydroxybenzoate; potassium sorbate; saccharin; polysorbate 80; diethanolamine; purified water; sodium metabisulfite; fragrance (perfume) - tuberculosis. in the initial treatment and in re-treatment of patients with tuberculosis, rifadin must be used in conjunction with at least one other antituberculosis drug. leprosy. in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. as an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. as an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. meningococcal disease. prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (rifadin is not indicated for the treatment of meningococcal infections). haemophilus influenzae. prophylaxis of household contacts of patients with h. influenzae type b.

Philippines - English - FDA (Food And Drug Administration)

rifampicin + isoniazid 150mg + 75mg tablet, film coated

j.m. tolmann labs inc - rifampicin , isoniazid - tablet, film coated - 150mg + 75mg

Philippines - English - FDA (Food And Drug Administration)

rifampicin + isoniazid + pyrodoxine hydrochloride (vit b6) 60mg + 30mg + 25mg suspension, oral

j.m. tolmann labs., inc - rifampicin , isoniazid , pyrodoxine hydrochloride (vit b6) - suspension, oral - 60mg + 30mg + 25mg